These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 13457857)

  • 1. [Critical analysis of recommended modern therapies of multiple sclerosis].
    KETELAER CJ
    Acta Neurol Psychiatr Belg; 1957 May; 57(5):372-406. PubMed ID: 13457857
    [No Abstract]   [Full Text] [Related]  

  • 2. [Complementary and alternative therapies for multiple sclerosis].
    Schwarz S; Leweling H; Sagstetter BU; Meinck HM
    Med Monatsschr Pharm; 2008 Mar; 31(3):89-98; quiz 99-100. PubMed ID: 18429530
    [No Abstract]   [Full Text] [Related]  

  • 3. Symptomatic therapies in multiple sclerosis. Introduction.
    Solaro C; Mancardi G
    Neurol Sci; 2008 Dec; 29 Suppl 4():S347. PubMed ID: 19089673
    [No Abstract]   [Full Text] [Related]  

  • 4. Disease modifying therapies in multiple sclerosis.
    Khatri BO; McQuillen MP
    Neurology; 2002 Aug; 59(3):472; author reply 472-3. PubMed ID: 12184316
    [No Abstract]   [Full Text] [Related]  

  • 5. Current evidence and therapeutic strategies for multiple sclerosis.
    Wingerchuk DM
    Semin Neurol; 2008 Feb; 28(1):56-68. PubMed ID: 18256987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple sclerosis and alternative medicine.
    Pleines J
    Axone; 1992 Jun; 13(4):123-4. PubMed ID: 1599863
    [No Abstract]   [Full Text] [Related]  

  • 7. A summary of the modern concepts of the treatment of disseminated sclerosis.
    PARSONS-SMITH G
    Med Illus; 1954 Apr; 8(4):255-7. PubMed ID: 13153719
    [No Abstract]   [Full Text] [Related]  

  • 8. [Critical considerations on sodium succinate therapy of multiple sclerosis].
    SERCL M; JAROS O; GROSSMANN V; KVETINA J
    Cesk Neurol; 1959 Feb; 22(1):11-9. PubMed ID: 13629629
    [No Abstract]   [Full Text] [Related]  

  • 9. [Critical study of intraspinal hydrocortisone therapy of multiple sclerosis].
    SIGWALD J; HEBERT H; QUETIN A; CLEMENT
    Sem Hop; 1957 Mar; 33(18):1149-53. PubMed ID: 13432871
    [No Abstract]   [Full Text] [Related]  

  • 10. Novel therapeutic strategies for multiple sclerosis--a multifaceted adversary.
    Lopez-Diego RS; Weiner HL
    Nat Rev Drug Discov; 2008 Nov; 7(11):909-25. PubMed ID: 18974749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opportunistic infections and other risks with newer multiple sclerosis therapies.
    Berger JR; Houff S
    Ann Neurol; 2009 Apr; 65(4):367-77. PubMed ID: 19399841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Non-conventional medicine and multiple sclerosis].
    Vermersch P; Zéphir H
    Rev Neurol (Paris); 2008 Mar; 164 Spec No 1():F7-13. PubMed ID: 18680811
    [No Abstract]   [Full Text] [Related]  

  • 13. [Multiple sclerosis in the XXI century].
    García Merino A
    Neurologia; 2004 Dec; 19(10):728-34. PubMed ID: 15568170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease-modifying drugs for the early treatment of multiple sclerosis.
    Flachenecker P
    Expert Rev Neurother; 2004 May; 4(3):455-63. PubMed ID: 15853542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multiple sclerosis: treatment and prevention of relapses and progression in multiple sclerosis].
    Saida T
    Rinsho Shinkeigaku; 2004 Nov; 44(11):796-8. PubMed ID: 15651294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using stem cells in multiple sclerosis therapies.
    Muraro PA; Cassiani-Ingoni R; Martin R
    Cytotherapy; 2004; 6(6):615-20. PubMed ID: 15764028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcome measures in multiple sclerosis.
    Amato MP; Portaccio E
    J Neurol Sci; 2007 Aug; 259(1-2):118-22. PubMed ID: 17376487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunomodulatory therapy in multiple sclerosis].
    Csépány T; Bereczki D
    Ideggyogy Sz; 2004 Nov; 57(11-12):401-16. PubMed ID: 15662768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple sclerosis.
    Cuddy ML
    J Pract Nurs; 2007; 57(2):5-6, 12; quiz 13-4. PubMed ID: 17941188
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunopathogenesis and immunotherapeutic approaches in multiple sclerosis.
    Lim ET; Giovannoni G
    Expert Rev Neurother; 2005 May; 5(3):379-90. PubMed ID: 15938671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.